Announcing Rosetta's Transition to a Public Repository (including Licensing Changes)

Dear Rosetta Community and users of Rosetta,


We're excited to announce that we have moved the Rosetta code repository to a public repository! We have made this move to honor our longstanding philosophy of sharing our work publicly and making it broadly accessible to scientists. This change marks a new chapter for Rosetta, where future developments will be more collaborative and accessible. 


This move required crucial changes to our workflow and licensing terms that are designed to streamline contributions to our platform. The new repository is accessible at https://github.com/RosettaCommons/rosetta.


Licensing adjustments:

The repository's public status means that non-commercial users no longer need to explicitly sign up for a license to access Rosetta. However, despite being publicly accessible, Rosetta is not open source; redistribution restrictions and other licensing restrictions remain in place for all users. For our commercial users, the existing license will continue as before, with no immediate changes. New commercial users will also be required to purchase a separate commercial license.


Code contributions:

With the repository now open, we welcome code contributions from both academic and commercial users outside of the Rosetta Commons. To contribute, non-Rosetta Commons contributors will first need to sign a Contributor License Agreement, ensuring a smooth integration of contributions into the Rosetta codebase. Scientists in Rosetta Commons labs remain able to contribute under the terms of their Institutional Participation Agreement and individual Developers Participation Agreement.


Workflow changes:

As previously announced, the old Rosetta/main repository is now closed for merges but will remain available to Rosetta Commons members. To align better with now-standard practices, we will now use the fork model workflow with the new RosettaCommons/rosetta repository. 

  • If you just want to use Rosetta, you can clone the new repository using standard Git/Github tools. 

  • If you want to develop Rosetta, you should fork the repository before cloning it to your local machine. You can then use the traditional branch model workflow that we've been using for many years, on your private fork. Contributions back to the main RosettaCommons/rosetta repository will be managed through pull requests. We are currently addressing some minor technical issues related to forks and automated testing and will update affected developers directly.


Should you have any questions or require further assistance, please feel free to reach out via Slack or email Rocco (rocco.moretti@vanderbilt.edu or @rmoretti) or Sergey (sergey.Lyskov@gmail.com or @sergey) for support.


The Rosetta Commons open repository team

(Rocco Moretti, David Nannemann, Sergey Lyskov, James Vasile)

Comments

Post a Comment

Popular posts from this blog

Introducing Rosetta Commons Foundation and Levitate Bio

Dear members of the Rosetta Community, The Rosetta Commons Board is excited to announce a significant milestone in the evolution of our community and a step on our path toward the Future of Rosetta. We have created a non-profit organization, the Rosetta Commons Foundation, which has established a wholly-owned subsidiary company called Levitate Bio. Levitate Bio provides cloud-based automated protein modeling and design protocols using AI & Rosetta, available through annual subscriptions. With a mission similar to the Rosetta Commons, the Rosetta Commons Foundation aims to foster a collaborative community that contributes to knowledge and tools for computational modeling and design of biological macromolecules. Appointed by the Rosetta Commons Board, the Foundation’s initial Board currently consists of Jeff Gray, Julia Koehler Leman, and David Nannemann. We expect this leadership structure to evolve soon, with a more permanent Board structure announced in due course. What is unique...
Read more

Announcing the winners of the Winter Protein Design Games 2024: Unleashing Innovation in Enzyme Engineering

Image
The Winter RosettaCon organizers want to thank Liberum Bio for sponsoring the experimental validation of the designs that they carried out in 8 days starting from digital sequences! Liberum Bio produces proteins at high yields in cell-free systems at a fraction of the usual cost and time via highly engineered strains and state-of-the art reaction mixtures. At Winter RosettaCon 2024 in Boston, the Rosetta Commons in partnership with Liberum Biotech hosted the inaugural Winter Protein Design Games , focusing on the design of Tobacco Etch Virus (TEV) protease variants. TEV protease is commonly used as a tool for sequence-specific protein cleavage, facilitating the purification of proteins without affinity tags. The competition challenged cross-institutional participating teams to engineer TEV proteases that exhibited enhanced substrate cleavage efficiency over the wild-type enzyme.  The competition was straightforward: design TEV protease variants that outperform the wild type in cl...
Read more